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Abstract
Purpose Only 30 % of IVF cycles result in a pregnancy, so
that multiple embryos need to be replaced, per treatment
cycle, to increase pregnancy rates, resulting in a multiple
gestation rate of 25 %. The use of new markers in the
gamete selection, could reduce the number of the oocytes
to be fertilized and embryos to be produced, but the tools to
evidence the gamete competence remain unavailable and
more studies are needed to identify bio-markers to select
the best oocyte and sperm to produce embryos with higher
implantation potentiality.
Methods To define oocyte competence, the apoptosis of the
surrounding cumulus cells and the oxygen consumption rates
for individual oocytes before fertilization seems to provide a
non-invasive marker of oocyte competence and hence a quan-
titative assessment of the reproductive potential for the oocyte.
The chromatin integrity seems to be used also as biological
marker of sperm competence, together with the morphological
evaluation of large vacuoles in the head.
Results The apoptosis rate of cumulus cells lower than
25 % and an higher oxygen consumption could be an
evidence of an overall metabolic activity, related to a
better fertilization ability and embryo cleavage quality.
The apoptosis rate of the sperm chromatin, evaluated by
direct Tunel in situ analysis, seems to be, also for the
male gamete, a marker of competence and implantation
potentiality, in particular when it is lower than 20 %.
The evaluation of the presence of large vacuoles in the
sperm head prior to perform ICSI seems to increase the
implantation rate, but it is not associated to chromatin
integrity.
Conclusions The biological concept of competence appears
unrelated to any morphological parameters, so that it is
necessary to investigate new molecular markers in the gam-
ete selection. Apoptosis of cumulus cells in the oocytes and
spermatozoa, revealing the presence of large vacuoles, could
help to determine the competence of the gamete to be
fertilize.
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Introduction
In the last years, new knowledge in the field of mammalian
gamete biology has allowed to define the new concept of
oocyte and sperm competence. The gamete competence is
the ability to undergo successful fertilization, reach the
blastocyst stage and implant in the uterus. Many researchers
are working to identify markers to select the best oocyte and
sperm to produce embryos with higher implantation poten-
tiality. Only 32 % of IVF cycles result in a pregnancy [1], so
that multiple embryos are replaced, per treatment cycle, to
increase pregnancy rates, resulting in a multiple gestation
rate of 25 %. Most of clinicians and embryologists, in the
Capsule To identify bio-markers to select the best oocyte and sperm to
produce embryos with higher implantation potentiality, is one of the
main interests of the researchers. Cumulus cells apoptosis, oocyte
oxygen consumption, vacuolization of sperm head and chromatin
integrity seems to be a promising tools.
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world, are changing strategies in the number of embryos to
be produced and transferred to avoid the risk of multiple
pregnancies. The single embryo transfer (SET) is a new
effective strategy to reduce multiple gestation rates, but its
widespread acceptance is limited because it lacks of an
accurate method of embryo assessment and selection for
transfer during IVF cycles.
The use of new markers in the gamete selection could
reduce the number of the oocytes to be fertilized and embryos
to be produced, in particular in the Countries where the law
limits the number of oocytes to be fertilized.
The oocyte competence
The oocyte is unique and highly specialized cell responsible
for creating, activating and controlling the embryonic ge-
nome, as well as supporting basic processes, such as cellular
homeostasis, metabolism and cell cycle progression in the
early embryo. Oocyte quality is also related to early embry-
onic survival, and the establishment and maintenance of
pregnancy, fetal development and adult disease. The biologi-
cal competence for the oocytes is defined as the intrinsic
ability to undergo meiotic maturation, fertilization, embryonic
development and successful pregnancy. The developmental
competence is gradually acquired during the long-lasting pe-
riod of oogenesis. But it is important the final stage for optimal
development, prior to ovulation, because the synchronization
between nuclear and cytoplasmic maturation in the oocytes is
completed [2].
Usually, in the IVF/ICSI clinical routine, the oocyte
selection is based on the morphological parameters of the
cytoplasm, polar body and cumulus cells [3, 4]. However,
all the morphological criteria for grading and screening of
oocytes are subjective and controversial, and seem to not be
related to the intrinsic competence of the oocyte [5, 6]. Lot
of research projects are designed to define objective and
non-invasive molecular markers predictive of oocyte com-
petence. What it is known is that the relationship between
the oocyte and the surrounding somatic cells is more com-
plex than previously thought, and represents a determining
factor of later developmental competence [7]. Acquisition of
oocyte competence is closely associated with normal follic-
ular development, whereby the oocyte plays an active role in
regulating the functions of surrounding somatic cells. It is
currently established that the communication between cu-
mulus cells and the oocyte is essential for the competence
acquisition process. Therefore, identification of key mole-
cules and signaling pathways within the oocyte–cumulus
cell regulatory loop will be instrumental in gaining deep
insights into the intricate mechanisms underlying the devel-
opment of oocyte competence and uncovering novel regu-
lators and reliable molecular predictors of oocyte quality.
These efforts will ultimately lead to improve efficiency and
health outcomes of ART (i.e. reduced prematurity/perinatal
mortality rate and maternal and pediatric complications) [2,
8, 9]. Oocytes clearly depend on the presence of follicle
cells to generate specific cellular signals that coordinate
their growth and maturation [10]. The fate of each follicle,
in the ovary, can evolve towards the ovulation through
specific pathways of follicular survival, or to the atresia in
which predominate the apoptosis pathway.
From follicular apoptosis new tools in oocyte selection?
It has been demonstrated that the percentage of apoptotic
cumulus cells in women who achieved pregnancy was con-
siderably fewer compared with women who did not become
pregnant. Moreover, DNA fragmentation in oocytes associ-
ated with apoptotic evidence might be one of the reasons for
poor oocyte quality and lower fertility in aged mice [11]. A
study on apoptosis in human oocytes collected in ICSI
cycles, showed that apoptosis occurs also in human oocytes
retrieved after hormonal stimulation and it is associated to
the oocyte quality [12].
Apoptosis of the oocyte and of the surrounding cumulus
cells can be used as a biological marker of competence? A
recent study has demonstrated that in vitro-matured oocytes
showed a higher rate of DNA fragmentation compared to in
vivo-matured oocytes. The cleavage and blastocyst forma-
tion rates of in vitro-matured oocytes were significantly
lower than those of in vivo-matured oocytes, evidence of a
lower competence. A possible cause of the reduced devel-
opmental competence of in vitro-matured oocytes may be
due to DNA fragmentation that was significantly higher
than in vivo-matured oocytes based on the presence and
length of the comet tail [13].
The affected developmental competence of in vitro ma-
tured oocytes could explain the lower implantation rate of
IVM treatment cycles compared to conventional gonadotro-
pin stimulated IVF cycles [14]. The use of DNA fragmen-
tation as a biological marker of oocyte competence cannot
be used to select the oocyte to be fertilized by ART. It is
important to underline that oocyte apoptosis could be evi-
dence of a non-adequate folliculogenesis in which are in-
volved also the cumulus and granulosa cells. The presence
of apoptosis in a pool of cumulus cells from immature
oocytes compared with cumulus cells from mature oocytes
in metaphase II was studied by Host et al. [15]. The study
demonstrated a significant increase in the number of apo-
ptotic cumulus cells in the pool of cells derived from imma-
ture oocytes (germinal vesicles and MI) compared with
cumulus cells derived from mature oocytes (metaphase II).
Although, during reproductive life, apoptosis is strictly re-
lated to the reduction of the number of follicles, we can
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speculate that apoptotic events in follicles selected after
hormonal stimulation, could be related to a reduced oocyte
developmental competence. In physiology, a dominant and
ovulating follicle should be a cellular compartment (theca,
granulosa, cumulus cells an oocyte) in which the surviving
pathway prevail over apoptosis. Thus, the chromatin integ-
rity of the granulosa/cumulus cells should be considered as
an important marker in defining adequate biological activity
that would allow optimum synchronization of cytoplasmic
and nuclear maturation of the oocyte. Different papers have
evaluated the apoptosis rate in the cumulus cells to verify
the relationship with clinical outcomes, in terms of pregnan-
cy and implantation rate, demonstrating that apoptotic rate
of cumulus cells could be used as a molecular marker in
selecting oocytes with higher implantation potentiality. Re-
cently, our study, focused on verifying whether the admin-
istration of LH could increase pregnancy and implantation
rates by improving the quality of oocytes collected after
multiple follicular growth therapy, has demonstrated that
the administration of r-LH during the late follicular phase
improves clinical outcomes, with an increased pregnancy
and implantation rates, that may be correlated with the
reduction of apoptosis evaluated in the cumulus cells of
patients treated with r-LH compared with patients treated
with r-FSH alone [16].
Apoptotic pathways
Close molecular communication between oocytes and gran-
ulosa cells exists during folliculogenesis (hypothesis of an
oocyte-granulosa cell regulatory loop), essential for induc-
ing and coordinating differentiation in the oocyte and in the
somatic compartment. Several molecules are involved in
specific pathways: oocyte growth differentiation factor 9
[17, 18], for example, seems to control the physiological
synchronization of cytoplasmic and nuclear maturation [19,
20]. The mRNA of epidermal growth factor (EGF) was also
found in granulosa, cumulus, and oocyte cells, and it acts on
granulosa and cumulus cells with a strong anti-apoptotic
effect [21]. Growth differentiation factor-9 synthesis is acti-
vated by EGF in the oocyte, with a positive effect on
cumulus cells. EGF has been identified in the follicular fluid
and shown to have a positive effect during the in vitro
maturation (IVM) of immature oocytes in a variety of spe-
cies, including cattle [22], pigs [23], rodents [24] and
humans [25], and its receptor has been demonstrated on
the surfaces of oocytes. The expression of EGF seems to
be induced by LH in the theca cells, and as a molecular
cascade, it involves granulosa, cumulus, and oocyte synthe-
sis of EGF [26], preserving these cells from apoptotic des-
tiny. New researches have confirmed the pivotal role of
different molecules of the EGF family in supporting the
survival pathways, playing an anti-apoptotic action [27,
28]. Other studies demonstrated that several molecules are
involved in the control of apoptosis, in particular the extra-
cellular signal-regulated kinase (ERK 1/2) pathway and the
phosphorylation and activation of Akt [29]. Another impor-
tant factor seems to be the Neuregulin-1(NRG-1) that acti-
vates PI3K/Akt signaling and inhibits apoptotic events [30].
New strategies in investigating oocyte competence
Oxygen consumption has often been regarded as a good
indicator of overall metabolic activity. The measurement of
Oxygen consumption rates for individual oocytes before
fertilization seems to provide, also, a noninvasive marker
of oocyte competence and hence a quantitative assessment
of the reproductive potential for the oocyte [31]. It has been
demonstrated that Oxygen consumption is related to fertil-
ization ability, which is consistent with previous data re-
garding higher ATP turnover in mature oocytes. Lower ATP
production (lower oxygen uptake) could compromise fertil-
ization and subsequent embryo cleavage, and it could be
used as an effective and non-invasive tool for selecting
competent oocyte.
Oocyte quality and subsequent embryo development can
be affected by factors such as nutrition, hormonal regula-
tion, and environmental influence. Several studies are trying
to identify genes expressed in oocytes and/or cumulus cells,
across a diverse range of species, which may be linked to the
ability of the oocyte to develop following fertilization. Some
of these seem to drive to the identification of 56 candidate
genes associated with oocyte quality across several species,
4 of which were identified in the cumulus cells that surround
the oocyte. Twenty-one potential biomarkers were associat-
ed with increased competence and 35 potential biomarkers
were associated with decreased competence [32]. These
genes could potentially act as biomarkers of oocyte compe-
tence or as pharmacological targets for manipulation in
order to improve oocyte developmental potential, but more
research is needed to apply in the routine of IVF clinic.
The sperm competence
In the last decade new knowledge on sperm biology,
allowed us to speculate that the concept of biological com-
petence could be considered also for the male gamete. The
traditional sperm parameters, concentration, progressive
motility and morphology, seem to be good marker to predict
clinical outcome in natural cycle [33], in intra-uterine in-
semination cycles [34] and in conventional IVF [35], but not
for ICSI outcome. The selection of a single sperm, accord-
ing to traditional parameters, does not allow embryologists
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to select the sperm with the highest developmental potential.
Routinely, the selection of the sperm before ICSI is per-
formed according to motility and morphology evaluation,
avoiding to use immotile and abnormal sperm, preferring
sperm with normal head (normal shape, normal size, having
an acrosome), no mid-piece and tail defects.
The chromatin integrity as biological marker of sperm
competence
During recent years, in assisted reproductive technology
(ART), in the clinical setting, the nuclear deterioration of
human sperm, in particular DNA fragmentation, as a conse-
quence of double-strand breaks, attracts attention, consider-
ing DNA fragmentation index (DFI) as an independent
predictor of fertility in couples undergoing intrauterine in-
semination [36]. In contrast to the standard semen parame-
ters, which do not act as powerful discriminators between
fertile and infertile men, sperm DNA damage assessment
seems to yield better prognostic value. It has been shown
that fecundity starts to decrease when sperm DFI exceeds
15 % [37]. Above a threshold of 30 %, chances for preg-
nancy are close to zero, either by means of natural concep-
tion or intrauterine insemination. This shows that the DFI
possesses a high predictive value for male infertility in vivo
[36]. Several authors have demonstrated a relationship be-
tween high DFI value and clinical outcomes in ART cycles.
If a sperm with damaged DNA is incorporated into the
embryonic genome, it may lead to sperm derived chromo-
somal aberrations [38] which may in turn result in higher
miscarriage rates [39] and an increased risk of pregnancy
loss [40]. The resultant aberrations can also be potentially
inherited through the germ line for generations.
Higher percentage of fragmented chromatin in a sperm
seminal sample compared with that of low chromatin frag-
mentation, is associated with a reduced pregnancy and im-
plantation rate after conventional IVF [41] and ICSI [42].
The DNA fragmentation could be related to different mod-
ification of gene expression and epigenome [43]. The high
magnification morphological selection of motile spermato-
zoa (MSOME) in performing IMSI, was proposed [44] to
increase ICSI clinical outcomes, emphasizing that sperm
morphology may have a significant impact on pregnancy
outcome in ICSI treatments. In particular, the authors fo-
cused on the role of large vacuoles in the sperm head
probably evidencing chromosomal or DNA defect. Other
authors have demonstrated that the presences of sperm
nuclear large vacuoles are related to an abnormal sperm
chromatin packaging [45].
A recent publication demonstrated that there is a close
relationship between nuclear vacuoles and clinical outcomes
after ICSI, confirming that the nuclear morphology could be
considered a morphological marker of developmental com-
petence, but without any relationship with the DNA frag-
mentation [46, 47]. To date, does not exit any tools to select
sperm with chromatin integrity. The IMSI, birefringence of
sperm head [48], Hyaluronic acid- sperm selection [49]
seem to increase the clinical outcome after ICSI, but none
of these techniques is associated with the quality and integrity
of the sperm chromatin.
Conclusions
The developmental fate of the embryo is principally dictated
by the oocyte and sperm competence. The biological con-
cept of competence seems to be not related to any morpho-
logical parameters, so that it is necessary to investigate new
molecular markers in the gamete selection. In the last years
an increased attention has been given to the gamete DNA
integrity and the epigenetic effects on the embryo develop-
ment. The embryologists know more about the molecular
communication between somatic and germinal cells in the
follicle, and about the molecules involved in the control of
surviving pathways, in particular in the dominant follicle.
Therefore, apoptosis of cumulus cells may be a marker of
oocyte competence and it could be an objective and non-
invasive molecular markers predictive of oocyte compe-
tence, to be used in selecting the best oocytes to be fertilized
in ART cycles. On the sperm side, only the morphological
evaluation, at higher magnification, of the sperm head nu-
cleus, that reveals the presence of large vacuoles, could help
to determine the competence of the sperm population pro-
vided for injection and is likely to play an important role in
ensuring the safety of clinical ICSI. It is necessary to im-
prove researches in better defining the biological conditions
that lead to the competence acquisition in the human game-
tes, so to give effective tools to select gametes with higher
development potential, to reduce the number of the oocytes
to be fertilized and embryos to be produced.
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